PACB
Pacific Biosciences of California, Inc.
1.74
2 x 1.55
2 x 2.15
bid
ask
+
0.00
0.00%
2 @ 08:55 AM
1.73 -0.01 (0.57%)
| Ytd | -6.95% | |
| 1y | 16.78% |
day range
1.09
52 week range
2.73
| Open | Prev Close | 1.74 | Low | High | Mkt Cap | 540.45M | |||
| Vol | 0.00 | Avg Vol | 6.30M | EPS | -0.41 | P/E | N/A | Forward P/E | -2.84 |
| Beta | 2.01 | Short Ratio | 4.46 | Inst. Own | 84.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.45 | 200-d Avg | 1.69 | 1yr Est | 3.02 |
| Income Statement | |||
| Total Revenue | 37.18M | ||
| Revenues (USD) | 37.18M | ||
| Cost of Revenue | 24.34M | ||
| Gross Profit | 12.84M | ||
| Operating Expenses | 21.20M | ||
| Research and Development Expense | 19.61M | ||
| Selling, General and Administrative Expense | 31.15M | ||
| Operating Income | -8.36M | ||
| Interest Expense | 1.74M | ||
| Income Tax Expense | 184.00K | ||
| Net Income | -8.27M | ||
| Net Income Common Stock | -8.27M | ||
| Net Income Common Stock (USD) | -8.27M | ||
| Consolidated Income | -8.27M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -6.35M | ||
| Earning Before Interest & Taxes (USD) | -6.35M | ||
| Weighted Average Shares | 305.82M | ||
| Weighted Average Shares Diluted | 305.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 56.29M | ||
| Cash and Equivalents (USD) | 56.29M | ||
| Investments | 221.26M | ||
| Investments Current | 219.69M | ||
| Investments Non-Current | 1.57M | ||
| Trade and Non-Trade Receivables | 29.35M | ||
| Current Assets | 369.52M | ||
| Property, Plant & Equipment Net | 65.22M | ||
| Total Assets | 782.37M | ||
| Debt Current | 277.00K | ||
| Total Debt | 703.39M | ||
| Current Liabilities | 65.36M | ||
| Debt Non-Current | 703.11M | ||
| Total Liabilities | 780.00M | ||
| Accumulated Retained Earnings (Deficit) | -2.70B | ||
| Accumulated Other Comprehensive Income | -147.00K | ||
| Shareholders Equity | 2.37M | ||
| Shareholders Equity (USD) | 2.37M | ||
| Assets Non-Current | 412.85M | ||
| Total Debt (USD) | 703.39M | ||
| Deferred Revenue | 19.88M | ||
| Goodwill and Intangible Assets | 331.87M | ||
| Inventory | 51.02M | ||
| Liabilities Non-Current | 714.64M | ||
| Trade and Non-Trade Payables | 13.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.07M | ||
| Net Cash Flow from Financing | 1.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.39M | ||
| Capital Expenditure | 46.96M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -1.90M | ||
| Issuance (Purchase) of Equity Shares | 1.44M | ||
| Net Cash Flow from Investing | 35.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.20M | ||
| Net Cash Flow from Operations | -44.69M | ||
| Share Based Compensation | 4.46M | ||